20
Ajinomoto Co Inc, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is L-GLUTAMIC ACID, with a corresponding US DMF Number 31649.
Remarkably, this DMF maintains an Active status since its submission on April 20, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 21, 2021, and payment made on November 30, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II